- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-04-02-2009
Pharmaceutical Technology
Report from: Europe
April 02, 2009
News
33
4
Although industry is tightening its belt, contract manufacturers across Europe are actually making out quite well by taking on additional projects and new roles.
In the Spotlight April 2009
April 02, 2009
In the Spotlight
33
4
Editors' Picks of Pharmaceutical Science & Technology Innovations
Silicone Microdroplets in Protein Formulations—Detection and Enumeration
April 02, 2009
Peer-Reviewed Research
33
4
The authors describe a novel analytical approach that uses the shape-analysis capabilities of MFI to detect and enumerate silicone oil microdroplets in protein formulations that also contain aggregates of similar size and in a similar concentration.
Reference-Standard Material Qualification
April 02, 2009
Peer-Reviewed Research
33
4
The author reviews the types of reference-standard materials used in drug-product manufacturing, discusses current regulatory requirements, and outlines a reference-standard qualification program.
Ever Vigilant (A Pharmacovigilance Book Review)
April 02, 2009
Online Exclusive
33
4
In a recent book, UK regulators explain how to establish a pharmacovigilance system.
Congress and Obama Seek to Bolster Drug Safety
April 02, 2009
Washington Report
33
4
FDA is poised to gain authority and resources to ensure the quality of food and drugs.
Deep Freeze: Innovations in Lyophilization
April 02, 2009
Special Report
33
4
By reducing cycle time and implementing quality-by-design inspired engineering, advanced lyophilization systems are driving the industry toward greater efficiency and control.
Insider Solutions: Device Database Can Help Pharma
April 02, 2009
Insider Solutions
33
4
Standards data is helpful, but FDA needs to apply its information across the board. This article contains bonus online-exclusive material.
Parallel Tracks
April 02, 2009
From The Editor
33
4
Obama's cost-containment and science-innovation initiatives need to overlap.
Tracking Excipients
April 02, 2009
Ingredients Insider
33
4
A review of recent product innovations, policy developments, and growth prospects in the excipients market.
Downpayment on Health Reform
April 02, 2009
Online Exclusive
33
4
President Obama's economic recovery plain includes goals such as reducing the number of uninsured citizens and improving the quality of healthcare.
The Value of In Vitro Dissolution in Drug Development
April 02, 2009
Peer-Reviewed Research
33
4
A Position Paper from the AAPS In Vitro Release and Dissolution Focus Group
Moving Toward a Drug Development Boon or Bust?
April 02, 2009
PharmTech Talk
33
4
The financial and economic downturn is likey to have long-term implications for outsourcing.
Automation Vendor or Partner?
April 02, 2009
Viewpoint
33
4
The role of automation suppliers is transforming to meet the pharma industry's demand for change.
Out of Control
April 02, 2009
Agent-In-Place
33
4
GMP agents report on old products, aseptic violations, and unexpected emotions.
Contract Organizations are the Sell of the Season
April 02, 2009
Outsourcing Outlook
33
4
Despite the market downturn, private equity investors are lining up for pharmaceutical services.